Effectiveness of Carbon Localization for Invasive Breast Cancer: An Institutional Experience.
Journal
The breast journal
ISSN: 1524-4741
Titre abrégé: Breast J
Pays: United States
ID NLM: 9505539
Informations de publication
Date de publication:
2023
2023
Historique:
received:
14
12
2022
revised:
21
05
2023
accepted:
08
07
2023
medline:
28
7
2023
pubmed:
27
7
2023
entrez:
27
7
2023
Statut:
epublish
Résumé
The final oncological and aesthetic results of breast-conserving surgery (BCS) are influenced by the precise localization of breast cancer (BC) tumors and by the quality of the intraoperative margin assessment technique. This study aimed to assess the effectiveness of the carbon localization (CL) technique by determining the success rate of BC identification and the proportion of adequate complete resection of BC lesions. We conducted a cross-sectional retrospective study of patients treated with primary BCS for invasive BC who underwent CL of their BC lesion at the Jules Bordet Institute between January 2015 and December 2017. Descriptive statistics with categorical and continuous variables were used. The success rate of tumor identification and the rate of adequate excision were calculated using the test of percentages for independent dichotomous data. This study included 542 patients with 564 nonpalpable BC lesions. The median pathological tumor size was 12 mm. Of these, 460 were invasive ductal carcinomas. Most of the tumors were of the luminal subtype. CL was performed using ultrasound guidance in 98.5% of cases. The median delay between CL and surgery was 5 days, with 46% of the patients having CL one day before surgery. The lumpectomy weighed 38 g on average, with a median diameter of the surgical sample at 6 cm and a median volume of 44 cm This study demonstrated high success rates for BC tumor identification (99%) and one-stage complete resection (93.4%) after BCS and CL. These results show that CL is an effective, simple, and inexpensive localization technique for successful excision of BC lesions during BCS.
Identifiants
pubmed: 37496746
doi: 10.1155/2023/4082501
pmc: PMC10368511
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4082501Informations de copyright
Copyright © 2023 Etienne El-Helou et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest.
Références
Eur J Breast Health. 2018 Dec 19;15(1):7-12
pubmed: 30816361
Asian Pac J Cancer Prev. 2016;17(S3):43-6
pubmed: 27165206
Gland Surg. 2022 Jan;11(1):258-269
pubmed: 35242687
Clin Radiol. 1998 Nov;53(11):845-8
pubmed: 9833790
Korean J Radiol. 2007 Jul-Aug;8(4):295-301
pubmed: 17673840
CA Cancer J Clin. 2022 Jan;72(1):7-33
pubmed: 35020204
Breast. 2022 Apr;62:103-113
pubmed: 35151049
Geburtshilfe Frauenheilkd. 2022 Sep 30;82(10):1031-1043
pubmed: 36186147
Acta Radiol Diagn (Stockh). 1983;24(2):145-51
pubmed: 6353873
Eur J Surg Oncol. 2022 Jan;48(1):53-59
pubmed: 34656392
Am J Surg. 2007 Oct;194(4):518-20
pubmed: 17826070
Breast. 2003 Aug;12(4):264-9
pubmed: 14659311
Acta Radiol Open. 2018 Dec 06;7(12):2058460118815726
pubmed: 30619625
Clin Radiol. 2002 Oct;57(10):937-44
pubmed: 12413920
Ann Surg Oncol. 2007 Aug;14(8):2233-8
pubmed: 17505861
Medicine (Baltimore). 2015 Mar;94(10):e605
pubmed: 25761181
Br J Surg. 2021 Jul 23;108(7):843-850
pubmed: 33638646
Radiology. 2001 Jan;218(1):255-60
pubmed: 11152811
Cancers (Basel). 2023 Feb 12;15(4):
pubmed: 36831516
Eur J Surg Oncol. 2017 Apr;43(4):649-657
pubmed: 27916314
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2022 Mar-Apr;41(2):100-107
pubmed: 35193816
Radiographics. 2019 Nov-Dec;39(7):1886-1906
pubmed: 31560614
Australas Radiol. 1991 Aug;35(3):237-41
pubmed: 1763986
Eur J Surg Oncol. 1995 Feb;21(1):47-9
pubmed: 7851552
Front Surg. 2021 Nov 23;8:757694
pubmed: 34888344
PLoS One. 2020 May 13;15(5):e0232690
pubmed: 32401779
Rev Col Bras Cir. 2012 Dec;39(6):469-75
pubmed: 23348642
Diagn Cytopathol. 2004 Feb;30(2):134-5
pubmed: 14755770
Biomed Res Int. 2022 Apr 18;2022:9605439
pubmed: 35480139